Sandra Rodríguez-Rodero

Sandra Rodríguez-Rodero

Auto-generated profile, based on publicly available information

Sandra Rodríguez-Rodero

Endocrinology and Nutrition Department, Hospital Universitario Central de Asturias (HUCA), Asturias, Spain

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
SRSandra Rodríguez-Rodero
Sandra Rodríguez-Rodero
Agustin FernandezAgustin Fernandez
Agustin Fernandez
Juan Luis Fernandez-MoreraJuan Luis Fernandez-Morera
Juan Luis Fernandez-Morera
PCPatricia Castro-Santos
Patricia Castro-Santos
GBGustavo F. Bayon
Gustavo F. Bayon
MFMario Fdez. Fraga
Mario Fdez. Fraga
The purpose of this study was to determine the global patterns of aberrant DNA methylation in thyroid cancer. We have used DNA methylation arrays to determine, for the first time, the genome-wide promoter methylation status of papillary, follicular, medullary, and anaplastic thyroid tumors. We identified 262 and 352 hypermethylated and 13 and 21 hypomethylated genes in differentiated papillary and follicular tumors, respectively. Interestingly, the other tumor types analyzed displayed more hypomethylated genes (280 in anaplastic and 393 in medullary tumors) than aberrantly hypermethylated genes (86 in anaplastic and 131 in medullary tumors). Among the genes indentified, we show that 4 potential tumor suppressor genes (ADAMTS8, HOXB4, ZIC1, and KISS1R) and 4 potential oncogenes (INSL4, DPPA2, TCL1B, and NOTCH4) are frequently regulated by aberrant methylation in primary thyroid tumors. In addition, we show that aberrant promoter hypomethylation-associated overexpression of MAP17 might promote tumor growth in thyroid cancer. Thyroid cancer subtypes present differential promoter methylation signatures, and nondifferentiated subtypes are characterized by aberrant promoter hypomethylation rather than hypermethylation. Additional studies are needed to determine the potential clinical interest of the tumor subtype-specific DNA methylation signatures described herein and the role of aberrant promoter hypomethylation in nondifferentiated thyroid tumors.

1 July 2005 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
ALAntonio López‐Vázquez
Antonio López‐Vázquez
Luis RodrigoLuis Rodrigo
Luis Rodrigo
JMJesús Martínez‐Borra
Jesús Martínez‐Borra
RPRamón Pérez
Ramón Pérez
MRManuel Rodríguez
Manuel Rodríguez
CLCarlos López‐Larrea
Carlos López‐Larrea
The aim of the present study was to investigate, in 152 Spanish patients infected with hepatitis C virus (HCV), the possibility that killer cell immu

1 June 2013 in Environmental Health Perspectives
Verified
Journal Article
Open access
STSalman M. Tajuddin
Salman M. Tajuddin
AAAndré F. S. Amaral
André F. S. Amaral
Agustin FernandezAgustin Fernandez
Agustin Fernandez
SRSandra Rodríguez-Rodero
Sandra Rodríguez-Rodero
RRRamón María Rodríguez
Ramón María Rodríguez
NMNuria Malats
Nuria Malats
Background: Altered DNA methylation has been associated with various diseases. Objective: We evaluated the association between levels of methylation in leukocyte DNA at long interspersed nuclear element 1 (LINE-1) and genetic and non-genetic characteristics of 892 control participants from the Spanish Bladder Cancer/EPICURO study. Methods: We determined LINE-1 methylation levels by pyrosequencing. Individual data included demographics, smoking status, nutrient intake, toenail concentrations of 12 trace elements, xenobiotic metabolism gene variants, and 515 polymorphisms among 24 genes in the one-carbon metabolism pathway. To assess the association between LINE-1 methylation levels (percentage of methylated cytosines) and potential determinants, we estimated beta coefficients (βs) by robust linear regression. Results: Women had lower levels of LINE-1 methylation than men (β = –0.7, p = 0.02). Persons who smoked blond tobacco showed lower methylation than nonsmokers (β = –0.7, p = 0.03). Arsenic toenail concentration was inversely associated with LINE-1 methylation (β = –3.6, p = 0.003). By contrast, iron (β = 0.002, p = 0.009) and nickel (β = 0.02, p = 0.004) were positively associated with LINE-1 methylation. Single nucleotide polymorphisms (SNPs) in DNMT3A (rs7581217-per allele, β = 0.3, p = 0.002), TCN2 (rs9606756-GG, β = 1.9, p = 0.008; rs4820887-AA, β = 4.0, p = 4.8 × 10–7; rs9621049-TT, β = 4.2, p = 4.7 × 10–9), AS3MT (rs7085104-GG, β = 0.7, p = 0.001), SLC19A1 (rs914238, TC vs. TT: β = 0.5 and CC vs. TT: β = –0.3, global p = 0.0007) and MTHFS (rs1380642, CT vs. CC: β = 0.3 and TT vs. CC; β = –0.8, global p = 0.05) were associated with LINE-1 methylation. Conclusions: We identified several characteristics, environmental factors, and common genetic variants that predicted DNA methylation among study participants.

22 June 2007 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
SRSandra Rodríguez‐Rodero
Sandra Rodríguez‐Rodero
SGSegundo Gonzalez
Segundo Gonzalez
Luis RodrigoLuis Rodrigo
Luis Rodrigo
Juan Luis Fernandez-MoreraJuan Luis Fernandez-Morera
Juan Luis Fernandez-Morera
JMJesús Martínez‐Borra
Jesús Martínez‐Borra
CLCarlos Lopez-Larrea
Carlos Lopez-Larrea

8 November 2010 in Tissue Antigens
Verified
Journal Article
Closed access
PDF file
Juan Luis Fernandez-MoreraJuan Luis Fernandez-Morera
Juan Luis Fernandez-Morera
VCV. Calvanese
V. Calvanese
SRS. Rodríguez-Rodero
S. Rodríguez-Rodero
ETEdelmiro Menéndez Torre
Edelmiro Menéndez Torre
MFMario Fdez. Fraga
Mario Fdez. Fraga

25 January 2007 in Rheumatology
Verified
Journal Article
Closed access
PDF file
RLR. Lopez-Arbesu
R. Lopez-Arbesu
FBF. J. Ballina-Garcia
F. J. Ballina-Garcia
MAM. Alperi-Lopez
M. Alperi-Lopez
ALAlejandro Lopez-Soto
Alejandro Lopez-Soto
SRS. Rodriguez-Rodero
S. Rodriguez-Rodero
SGS. Gonzalez
S. Gonzalez
Objectives. Several recent studies have shown that the MHC class III region, located telomeric to HLA-DRB1, contains an additional genetic factor that predisposes to rheumatoid arthritis (RA). In this study, we investigate whether inhibitor of κB-like (IκBL), MICB or MICA located in the MHC class III region are the second susceptibility gene associated with RA.